Cerebral Small Vessels Disease Completed Phase 2 Trials for Cilostazol (DB01166)

Also known as: Cerebral Small-vessel Disease / Cerebral Small Vessel Disease / Cerebral Small Vessel Diseases / Cerebral small vessel ischaemic disease / Cerebral small vessel ischemic disease

IndicationStatusPhase
DBCOND0072196 (Cerebral Small Vessels Disease)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02481323Lacunar Intervention Trial 1 (LACI-1)Prevention